发明名称 |
Combination for the treatment of endothelial damage |
摘要 |
The invention relates to a combination of (a) an inhibitor of platelet-derived growth factor (PDGF) activity and (b) a vector for vascular endothelial growth factor (VEGF-, especially VEGF-C) gene transfer, a pharmaceutical preparation comprising (a) and (b) in combination together with a pharmaceutically acceptable carrier material; a product comprising (a) and (b) as defined above and optionally a pharmaceutically acceptable carrier material, for simultaneous, chronologically staggered or separate use; a method of administering or the use of said combination or product for the treatment of endothelial damage; and/or to the use of (a) and (b) for the manufacture of said pharmaceutical preparation or product for the treatment of endothelial damage.
|
申请公布号 |
US2003099687(A1) |
申请公布日期 |
2003.05.29 |
申请号 |
US20020227081 |
申请日期 |
2002.08.23 |
申请人 |
ALITALO KARI;HELDIN CARL-HENRIK;LEPPANEN OLLI;OSTMAN ARNE;YLA-HERTTUALA SEPPO |
发明人 |
ALITALO KARI;HELDIN CARL-HENRIK;LEPPANEN OLLI;OSTMAN ARNE;YLA-HERTTUALA SEPPO |
分类号 |
A61K48/00;(IPC1-7):A61K48/00 |
主分类号 |
A61K48/00 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|